Smith & Nephew PLC

15 Minute Delayed Share Price Glossary Go to Portfolio
Current Chg % Chg Open High Low Volume
635.50
+3.00
0.47% 631.50 639.00 631.50 2.13m

Share Price Chart

label: share priceshare price chart showing price and earning per share against datelabel: earning per share

Broker Recommendation (7 Brokers)

STRONG SELL STRONG BUY
HOLD
Key Figures
Market Cap. £5,606.71m PER (pr) 14.8x EPS Growth (pr) 11.8% ROCE/ROIC 35.74%
Shares in issue 886.44m PEG (pr) 1.25f DY (pr) 1.54% Net Gearing 78.2%
Company Background
Sector Health
Activities Development, manufacture, marketing and sales of medical devices
TIDM SN.
Index FTSE 100, FTSE 350, Eurotop 300, S&P Europe 350, FTSE All Share, FTSE Techmark All Share, FTSE techMARK 100
Listed LSE - Full

Outlook

(6/11/2009) 3QT: "We remain confident in our ability to deliver a good outcome for the full year"
Latest Results
3rd Quarter 27/9/2008 26/9/2009
Turnover £m 1545.11 1691.88
Pre-tax Profit £m 218.63 309.49
EPS (Norm Dil.) p 19.36 27.36
Dividend p 3.7 5.57
Notes Figures from 2003 in accordance with IFRS. USD to GBP, 2005: 1.72030, 2006: 1.96330, 2007: 2.0077, 2008: 1.45820
Investment Ratios
  Co. FTSE Sector Market
PER (pr) x 14.79 13.35 11.02
Dividend Yield (pr) % 1.54 1.76 4.05
PEG (pr) f 1.25 1.07 -0.40
ROCE % 35.74 26.20 124.67
Operating Margin % 19.15 -10.73 9.32
EPS Growth (pr) % 11.82 16.52 16.64
EV/EBITDA x 6.99 6.97 6.94
Net Gearing % 78.16 71.69 150.58
Net Tangible Asset Value PS p 10.16 0.12 1.20
Price to Tangible Book Value (PTBV) x 62.29 -0.83 0.56
Price to Cashflow (PCF) x 14.44 14.02 9.70
Price to Sales Ratio (PSR) x 2.15 2.15 2.16
Definitions | Disclaimer
Data provided by Morningstar.
© Copyright 2009 Morningstar. All rights reserved. Please read our Terms of Use and Privacy Policy.